PYCARD expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.452200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.983600E-01
Normal-vs-Stage2
9.468800E-01
Normal-vs-Stage3
7.286000E-01
Normal-vs-Stage4
1.324210E-01
Stage1-vs-Stage2
4.541000E-01
Stage1-vs-Stage3
9.328000E-01
Stage1-vs-Stage4
7.496600E-01
Stage2-vs-Stage3
6.165400E-01
Stage2-vs-Stage4
3.120600E-01
Stage3-vs-Stage4
6.372000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.235600E-01
Normal-vs-AfricanAmerican
5.200400E-01
Normal-vs-Asian
3.871800E-01
Caucasian-vs-AfricanAmerican
4.361600E-01
Caucasian-vs-Asian
6.933500E-02
AfricanAmerican-vs-Asian
8.117800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.905000E-01
Normal-vs-Female
8.714600E-01
Male-vs-Female
5.859800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.478000E-01
Normal-vs-Age(41-60Yrs)
9.700800E-01
Normal-vs-Age(61-80Yrs)
8.957400E-01
Normal-vs-Age(81-100Yrs)
7.751400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.706400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.761400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.540400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.190600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.735800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.876400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.026600E-01
Normal-vs-Daily Drinker
5.893200E-01
Normal-vs-Weekly Drinker
9.076000E-01
Normal-vs-Occasional Drinker
6.606800E-01
Normal-vs-Social Drinker
7.854600E-01
Non Drinker-vs-Daily Drinker
2.624600E-01
Non Drinker-vs-Weekly Drinker
6.655200E-01
Non Drinker-vs-Occasional Drinker
2.687000E-01
Non Drinker-vs-Social Drinker
6.491400E-01
Daily Drinker-vs-Weekly Drinker
2.267000E-01
Daily Drinker-vs-Occasional Drinker
6.767500E-02
Daily Drinker-vs-Social Drinker
7.479400E-01
Weekly Drinker-vs-Occasional Drinker
5.737800E-01
Weekly Drinker-vs-Social Drinker
4.995800E-01
Occasional Drinker-vs-Social Drinker
3.084800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.015400E-01
Normal-vs-Grade 2
1.523770E-01
Normal-vs-Grade 3
1.513770E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.989660E-02
Grade 1-vs-Grade 3
5.080100E-03
Grade 1-vs-Grade 4
6.015400E-01
Grade 2-vs-Grade 3
1.147790E-01
Grade 2-vs-Grade 4
1.523770E-01
Grade 3-vs-Grade 4
1.513770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.118600E-01
Normal-vs-NonDiabetic
9.656800E-01
Diabetic-vs-NonDiabetic
6.360200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.453400E-01
Normal-vs-NoPancreatitis
8.610000E-01
Pancreatitis-vs-NoPancreatitis
1.377170E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.449600E-01
Normal-vs-N1
9.854200E-01
N0-vs-N1
4.406800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.827800E-01
Normal-vs-TP53-NonMutant
3.165600E-01
TP53-Mutant-vs-TP53-NonMutant
1.318760E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
